Details of Drug

Drug General Information (ID: D0692)
Drug Name	Fosamprenavir
Drug Type	Small molecule
Drug Synonymous	Telzir; Amprenavir phosphate; Fosamprenavir [INN]; GW 433908; GW433908; VX 175; Fosamprenavir (INN); Lexiva (TM); Lexiva (TN); Telzir (TN); Telzir(TM); VX-175; GW433908A (Sodium Salt); GW433908G (Calcium Salt); [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester; ((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-(phosphonooxy)propyl)carboxamide; (3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester Click to Show/Hide
Disease Class	1C60-1C62: Human immunodeficiency virus disease
Therapeutic Class	Anti-Hiv Agents
Structure
Structure	3D Structure		2D Structure
Formula	C25H36N3O9PS
InChI	1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1
InChIKey	MLBVMOWEQCZNCC-OEMFJLHTSA-N
Canonical SMILES	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
External Link
	Pubchem ID	131536
	CAS Number	226700-79-4
	CHEBI ID	82941
	TTD ID	D0F5MT
	INTEDE ID	DR0745
	VARIDT ID	DR01274

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM007 Pharmacodynamic antagonistic effects BM005 Altered gastric pH BM009 Altered absorption (Unspecific) BM010 Transporter inhibition BM011 Transporter induction BM012 Competitive inhibition of transporters BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM023 UGT induction BM086 Antagonize the effect of antidiabetic agents BM089 Antagonize the effect of antihypertensive agents BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Fosamprenavir
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[22]
D0603		Esomeprazole	C17H19N3O3S	9568614	Moderate		Inter Info	[22]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[22]
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Moderate		Inter Info	[22]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Moderate		Inter Info	[22]
D1151		Nizatidine	C12H21N5O2S2	3033637	Moderate		Inter Info	[22]
D1179		Omeprazole	C17H19N3O3S	4594	Moderate		Inter Info	[22]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Moderate		Inter Info	[22]
D1373		Rabeprazole	C18H21N3O3S	5029	Moderate		Inter Info	[22]
D1381		Ranitidine	C13H22N4O3S	3001055	Moderate		Inter Info	[22]
D1382		Ranitidine (bismuth citrate)	C13H22N4O3S	3001055	Moderate		Inter Info	[22]
	Altered absorption (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1187		Orlistat	C29H53NO5	3034010	Moderate		Inter Info	[566]
Affected cellular transport
	Transporter inhibition					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[531], [532], [533]
D1710		Voxilaprevir	C40H52F4N6O9S	89921642	Moderate		Inter Info	[549]
	Transporter induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0026		Afatinib	C24H25ClFN5O3	10184653	Moderate		Inter Info	[486]
	Competitive inhibition of transporters					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1791		Gadobenic acid	C22H28GdN3O11	9852779	Moderate		Inter Info	[550], [551]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 306
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0035		Alfentanil	C21H32N6O3	51263	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]
D0036		Alfuzosin	C19H27N5O4	2092	Major		Inter Info	[15], [16], [17], [18], [19]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[20], [16], [21], [22]
D0115		Astemizole	C28H31FN4O	2247	Major		Inter Info	[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [21], [44], [45], [46], [22], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59]
D0120		Atorvastatin	C33H35FN2O5	60823	Major		Inter Info	[60], [16], [27], [61], [62], [39], [63], [21], [44], [45], [22], [47], [48], [49], [50], [64]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[20], [16], [21], [22]
D0215		Budesonide	C25H34O6	5281004	Major		Inter Info	[65], [15], [16], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[16], [79], [80], [81]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[82], [83], [27], [84], [85], [86], [87], [62], [39], [88], [89], [21], [44], [45], [75], [22], [47], [48], [90], [49], [76], [50]
D0386		Conivaptan	C32H26N4O2	151171	Major		Inter Info	[15], [91], [18], [92]
D0402		Cyclosporine	C62H111N11O12	5284373	Major		Inter Info	[93], [21], [44], [45], [22], [94], [47], [48], [49], [50]
D0424		Darifenacin	C28H30N2O2	444031	Major		Inter Info	[15], [95], [96], [18]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[15], [18], [97]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[21], [22], [98]
D0450		Desogestrel	C22H30O	40973	Major		Inter Info	[99], [100], [22]
D0494		Dihydroergotamine	C33H37N5O5	10531	Major		Inter Info	[101], [102], [103], [20], [16], [104], [105], [106], [39], [107], [108], [21], [109], [44], [110], [45], [75], [22], [111], [47], [48], [49], [76], [50], [112], [113], [114], [115], [116]
D0511		Docetaxel	C43H53NO14	148124	Major		Inter Info	[117], [15], [16], [118], [119], [18], [120], [121], [122], [123]
D0557		Eletriptan	C22H26N2O2S	77993	Major		Inter Info	[124]
D0585		Eplerenone	C24H30O6	443872	Major		Inter Info	[15], [125], [18]
D0592		Ergometrine	C19H23N3O2	443884	Major		Inter Info	[101], [104], [106]
D0593		Ergotamine	C33H35N5O5	8223	Major		Inter Info	[101], [102], [103], [20], [16], [104], [105], [106], [39], [107], [108], [21], [109], [44], [110], [45], [75], [22], [111], [47], [48], [49], [76], [50], [112], [113], [114], [115], [116]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[126], [127]
D0612		Eszopiclone	C17H17ClN6O3	969472	Major		Inter Info	[128], [129], [27], [130], [131]
D0619		Ethinylestradiol	C20H24O2	5991	Major		Inter Info	[99], [100], [22]
D0626		Etonogestrel	C22H28O2	6917715	Major		Inter Info	[99], [100], [22]
D0646		Fentanyl	C22H28N2O	3345	Major		Inter Info	[15], [132], [133], [134], [18], [135], [13]
D0008		Acalabrutinib	C26H23N7O2	71226662	Major		Inter Info	[136]
D0108		Artemether	C16H26O5	68911	Major		Inter Info	[15], [16], [137]
D0128		Avanafil	C23H26ClN7O3	9869929	Major		Inter Info	[138]
D0129		Avapritinib	C26H27FN10	118023034	Major		Inter Info	[16], [139]
D0133		Axitinib	C22H18N4OS	6450551	Major		Inter Info	[15], [16], [140], [18]
D0161		Benzhydrocodone	C25H25NO4	49836084	Major		Inter Info	[141], [142], [143]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Major		Inter Info	[144]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[15], [16], [145], [18]
D0251		Capmatinib	C23H17FN6O	25145656	Major		Inter Info	[146]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Major		Inter Info	[147]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[15], [18], [148]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Major		Inter Info	[15], [149], [18]
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[150], [151], [152], [153], [154], [155], [156], [157], [158], [22], [159], [160], [161], [162], [163], [164], [165]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[15], [18], [166]
D0436		Deflazacort	C25H31NO6	189821	Major		Inter Info	[16], [167]
D0485		Dienogest	C20H25NO2	68861	Major		Inter Info	[99], [100], [22]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[15], [170], [18]
D0536		Drospirenone	C24H30O3	68873	Major		Inter Info	[15], [16], [171], [172], [173], [76], [174]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[15], [16], [175], [18]
D0571		Enfortumab vedotin	NA	NA	Major		Inter Info	[16], [176], [177], [178]
D0577		Entrectinib	C31H34F2N6O2	25141092	Major		Inter Info	[15], [16], [179]
D0590		Erdafitinib	C25H30N6O2	67462786	Major		Inter Info	[180]
D0629		Everolimus	C53H83NO14	6442177	Major		Inter Info	[15], [181], [182], [18]
D0638		Fedratinib	C27H36N6O3S	16722836	Major		Inter Info	[16], [183]
D0655		Fesoterodine	C26H37NO3	6918558	Major		Inter Info	[15], [18], [184], [185]
D0665		Flibanserin	C20H21F3N4O	6918248	Major		Inter Info	[186]
D0683		Fluticasone	C22H27F3O4S	5311101	Major		Inter Info	[187], [188], [189], [190], [66], [191], [192], [193], [194], [195], [196], [197], [198], [71], [199], [200], [201], [73], [202], [203], [204], [205], [206], [207], [208], [209], [47], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222]
D0684		Fluticasone (nasal)	C22H27F3O4S	5311101	Major		Inter Info	[47], [210], [222]
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[16], [227]
D0785		Ibrutinib	C25H24N6O2	24821094	Major		Inter Info	[228]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[229]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Major		Inter Info	[230]
D0866		Istradefylline	C20H24N4O4	5311037	Major		Inter Info	[231]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[15], [16], [232], [18]
D0869		Ivacaftor	C24H28N2O3	16220172	Major		Inter Info	[15], [16], [233], [234], [235], [236]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Major		Inter Info	[15], [16], [238]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[239]
D0901		Lemborexant	C22H20F2N4O2	56944144	Major		Inter Info	[15], [240]
D0920		Levomilnacipran	C15H22N2O	6917779	Major		Inter Info	[241]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[15], [242], [18]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[243]
D0959		Lumateperone	C24H28FN3O	21302490	Major		Inter Info	[244]
D0961		Lurasidone	C28H36N4O2S	213046	Major		Inter Info	[15], [16], [245]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Major		Inter Info	[246]
D0966		Macitentan	C19H20Br2N6O4S	16004692	Major		Inter Info	[247]
D0980		Maraviroc	C29H41F2N5O	3002977	Major		Inter Info	[248]
D1104		Naloxegol	C34H53NO11	56959087	Major		Inter Info	[15], [16], [249], [18]
D1124		Neratinib	C30H29ClN6O3	9915743	Major		Inter Info	[250], [15], [251]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[15], [18], [252]
D1157		Norgestrel	C21H28O2	13109	Major		Inter Info	[99], [100], [22]
D1167		Olaparib	C24H23FN4O3	23725625	Major		Inter Info	[15], [16], [253]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[254], [255]
D1189		Osilodrostat	C13H10FN3	44139752	Major		Inter Info	[16], [256]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[257]
D1214		Palbociclib	C24H29N7O2	5330286	Major		Inter Info	[258]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[15], [18], [259]
D1242		Pemigatinib	C24H27F2N5O4	86705695	Major		Inter Info	[16], [260]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[261]
D1290		Pimavanserin	C25H34FN3O2	10071196	Major		Inter Info	[262]
D1306		Polatuzumab vedotin	NA	NA	Major		Inter Info	[263]
D1313		Ponatinib	C29H27F3N6O	24826799	Major		Inter Info	[15], [16], [264]
D1324		Pralsetinib	C27H32FN9O2	129073603	Major		Inter Info	[265]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[16], [266]
D1434		Ruxolitinib	C17H18N6	25126798	Major		Inter Info	[267]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[16], [268]
D1460		Selumetinib	C17H15BrClFN4O3	10127622	Major		Inter Info	[269]
D1466		Silodosin	C25H32F3N3O4	5312125	Major		Inter Info	[15], [270], [18]
D1471		Simeprevir	C38H47N5O7S2	24873435	Major		Inter Info	[15], [271], [18]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[15], [272]
D1491		Solifenacin	C23H26N2O2	154059	Major		Inter Info	[15], [16], [18], [184], [273]
D1496		Sonidegib	C26H26F3N3O3	24775005	Major		Inter Info	[274]
D1524		Suvorexant	C23H23ClN6O2	24965990	Major		Inter Info	[276]
D1538		Tazemetostat	C34H44N4O4	66558664	Major		Inter Info	[277]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[15], [16], [278]
D1608		Tolvaptan	C26H25ClN2O3	216237	Major		Inter Info	[15], [91], [18], [92]
D1615		Trabectedin	C39H43N3O11S	108150	Major		Inter Info	[15], [16], [279], [18], [280]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[281]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Major		Inter Info	[15], [16], [282]
D1696		Vilazodone	C26H27N5O2	6918314	Major		Inter Info	[283]
D1705		Vorapaxar	C29H33FN2O4	10077130	Major		Inter Info	[15], [18], [284]
D1709		Voxelotor	C19H19N3O3	71602803	Major		Inter Info	[285]
D1718		Zanubrutinib	C27H29N5O3	135565884	Major		Inter Info	[286]
D0745		Guanfacine	C9H9Cl2N3O	3519	Major		Inter Info	[16], [287]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[288], [289], [290], [291], [292]
D0772		Hydrocodone	C18H21NO3	5284569	Major		Inter Info	[141], [142]
D0845		Irinotecan	C33H38N4O6	60838	Major		Inter Info	[20], [15], [16], [293], [294], [295], [296]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Major		Inter Info	[16], [293], [294]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Major		Inter Info	[15], [18], [297]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[298], [243]
D0922		Levonorgestrel	C21H28O2	13109	Major		Inter Info	[99], [100], [22]
D0927		Lidocaine	C14H22N2O	3676	Major		Inter Info	[20], [16], [21], [22]
D0956		Lovastatin	C24H36O5	53232	Major		Inter Info	[60], [16], [299], [27], [61], [300], [62], [39], [301], [63], [21], [44], [45], [22], [47], [48], [49], [50], [302]
D0990		Medroxyprogesterone acetate	C24H34O4	6279	Major		Inter Info	[99], [100], [22]
D1037		Methylergometrine	C20H25N3O2	8226	Major		Inter Info	[101], [104], [106]
D1041		Methylprednisolone	C22H30O5	6741	Major		Inter Info	[303], [17], [304], [305], [306], [307], [308], [309]
D1043		Methysergide	C21H27N3O2	9681	Major		Inter Info	[101], [104], [106]
D1060		Midazolam	C18H13ClFN3	4192	Major		Inter Info	[60], [310], [27], [311], [84], [312], [62], [39], [313], [88], [314], [21], [44], [45], [22], [47], [48], [49], [50]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[315], [316]
D1154		Norethisterone	C20H26O2	6230	Major		Inter Info	[99], [100], [22]
D1156		Norgestimate	C23H31NO3	6540478	Major		Inter Info	[99], [100], [22]
D1203		Oxycodone	C18H21NO4	5284603	Major		Inter Info	[15], [16], [317]
D1212		Paclitaxel	C47H51NO14	36314	Major		Inter Info	[318], [319], [320], [321], [120], [322], [323]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Major		Inter Info	[318], [321], [120]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[15], [324], [27], [325], [326], [327], [39], [328], [18]
D1368		Quetiapine	C21H25N3O2S	5002	Major		Inter Info	[329], [330], [331], [332], [333], [334], [335], [336], [337]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[20], [16], [21], [22]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[15], [16], [338], [18]
D1440		Salmeterol	C25H37NO4	5152	Major		Inter Info	[15], [16], [347], [18]
D1465		Sildenafil	C22H30N6O4S	135398744	Major		Inter Info	[60], [348], [349], [350], [351], [352], [21], [44], [45], [75], [22], [47], [48], [353], [49], [354], [76], [50], [355]
D1473		Simvastatin	C25H38O5	54454	Major		Inter Info	[60], [16], [299], [27], [61], [300], [62], [39], [301], [63], [21], [44], [45], [22], [47], [48], [49], [50], [302]
D1476		Sirolimus	C51H79NO13	5284616	Major		Inter Info	[15], [356], [357], [358], [359], [360], [18], [361], [76]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[362], [363], [364], [365], [366], [367], [368], [21], [44], [45], [22], [47], [48], [369], [49], [50], [370], [371], [372]
D1534		Tamsulosin	C20H28N2O5S	129211	Major		Inter Info	[15], [373], [374], [375], [18]
D1555		Terfenadine	C32H41NO2	5405	Major		Inter Info	[23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [21], [44], [45], [46], [22], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[376]
D1628		Triamcinolone	C21H27FO6	31307	Major		Inter Info	[303], [377], [378], [17], [379], [380], [381], [382], [383], [384], [385], [386]
D1632		Triazolam	C17H12Cl2N4	5556	Major		Inter Info	[60], [310], [27], [311], [84], [312], [62], [39], [313], [88], [314], [21], [44], [45], [22], [47], [48], [49], [50]
D1697		Vinblastine	C46H58N4O9	13342	Major		Inter Info	[387], [388], [389], [390], [391], [392], [20], [393], [15], [16], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403], [404], [405], [406], [407], [408], [409], [410], [411], [412], [413], [18], [414], [415], [416], [417], [418], [419], [420], [421], [422], [423]
D1698		Vincristine	C46H56N4O10	5978	Major		Inter Info	[387], [388], [389], [390], [391], [392], [20], [393], [15], [16], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403], [404], [405], [406], [407], [408], [409], [410], [411], [412], [413], [18], [414], [415], [416], [417], [418], [419], [420], [421], [422], [423]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Major		Inter Info	[390], [412], [414]
D1700		Vinorelbine	C45H54N4O8	5311497	Major		Inter Info	[387], [388], [389], [390], [391], [392], [20], [393], [15], [16], [394], [395], [396], [397], [398], [399], [400], [401], [402], [403], [404], [405], [406], [407], [408], [409], [410], [411], [412], [413], [18], [414], [415], [416], [417], [418], [419], [420], [421], [422], [423]
D0028		Albendazole	C12H15N3O2S	2082	Moderate		Inter Info	[21], [22], [427]
D0041		Almotriptan	C17H25N3O2S	123606	Moderate		Inter Info	[428]
D0043		Alosetron	C17H18N4O	2099	Moderate		Inter Info	[429]
D0045		Alprazolam	C17H13ClN4	2118	Moderate		Inter Info	[46], [430]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[434], [435], [436], [437], [438], [439], [440], [21], [22], [49], [441], [442], [443], [444], [445], [446], [447]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[20], [15], [16], [448], [449]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[450], [451]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[452]
D0172		Betamethasone	C22H29FO5	9782	Moderate		Inter Info	[303], [188], [65], [453], [454], [69], [17], [455], [456], [304], [195], [196], [457], [305], [306], [307], [458], [72], [459], [77], [78], [214], [460], [308], [309], [461], [462], [463], [221]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[464], [465], [466]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[15], [16], [343], [44], [320], [46], [467], [22], [48], [49], [50]
D0212		Bromocriptine	C32H40BrN5O5	31101	Moderate		Inter Info	[21], [22], [427]
D0216		Budesonide (nasal)	C25H34O6	5281004	Moderate		Inter Info	[65], [15], [16]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[468]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[21], [22], [427]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[469]
D0317		Chlordiazepoxide	C16H14ClN3O	2712	Moderate		Inter Info	[21], [22], [427]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[15]
D0338		Cinacalcet	C22H22F3N	156419	Moderate		Inter Info	[470]
D0354		Clindamycin	C18H33ClN2O5S	446598	Moderate		Inter Info	[471]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[21], [22], [427]
D0362		Clonazepam	C15H10ClN3O3	2802	Moderate		Inter Info	[21], [22], [427]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Moderate		Inter Info	[21], [22]
D0377		Cocaine (nasal)	C17H21NO4	446220	Moderate		Inter Info	[21], [22]
D0378		Cocaine (topical)	C17H21NO4	446220	Moderate		Inter Info	[21], [22]
D0400		Cyclophosphamide	C7H15Cl2N2O2P	2907	Moderate		Inter Info	[21], [22], [427]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[15], [16], [47]
D0454		Dexamethasone (nasal)	C22H29FO5	5743	Moderate		Inter Info	[69], [455], [214]
D0455		Dexamethasone (ophthalmic)	C22H29FO5	5743	Moderate		Inter Info	[69], [455], [214]
D0473		Diazepam	C16H13ClN2O	3016	Moderate		Inter Info	[21], [22], [427]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[21], [22], [427]
D0508		Disopyramide	C21H29N3O	3114	Moderate		Inter Info	[21], [22], [427]
D0513		Dofetilide	C19H27N3O5S2	71329	Moderate		Inter Info	[472]
D0524		Doxazosin	C23H25N5O5	3157	Moderate		Inter Info	[20], [16], [473]
D0535		Droperidol	C22H22FN3O2	3168	Moderate		Inter Info	[303], [474], [15], [16], [475], [476], [477]
D0542		Dutasteride	C27H30F6N2O2	6918296	Moderate		Inter Info	[478]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[482], [483]
D0604		Estazolam	C16H11ClN4	3261	Moderate		Inter Info	[21], [22], [427]
D0620		Ethosuximide	C7H11NO2	3291	Moderate		Inter Info	[21], [22], [427]
D0640		Felodipine	C18H19Cl2NO4	3333	Moderate		Inter Info	[21], [22], [427]
D0672		Flunisolide	C24H31FO6	82153	Moderate		Inter Info	[303], [188], [65], [453], [454], [69], [17], [455], [456], [304], [195], [196], [457], [305], [306], [307], [458], [72], [459], [77], [78], [214], [460], [308], [309], [461], [462], [463], [221]
D0673		Flunisolide (nasal)	C24H31FO6	82153	Moderate		Inter Info	[69], [455], [214]
D0674		Fluorometholone (ophthalmic)	C22H29FO4	9878	Moderate		Inter Info	[69], [455], [214]
D0679		Flurazepam	C21H23ClFN3O	3393	Moderate		Inter Info	[21], [22], [427]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[484]
D0006		Abemaciclib	C27H32F2N8	46220502	Moderate		Inter Info	[485]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[20], [16], [487], [488]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[16], [489], [427]
D0130		Avatrombopag	C29H34Cl2N6O3S2	9852519	Moderate		Inter Info	[16]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[494]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[16], [177], [75]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[15], [495], [18]
D0333		Ciclesonide	C32H44O7	6918155	Moderate		Inter Info	[303], [17], [496], [497]
D0334		Ciclesonide (nasal)	C32H44O7	6918155	Moderate		Inter Info	[498], [499], [496]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[15], [16], [320], [500], [171], [48], [501], [502], [503], [504]
D0389		Copanlisib	C23H28N8O4	135565596	Moderate		Inter Info	[505]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[15], [18], [506]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[15], [16], [507]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[508], [509]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[510]
D0562		Eluxadoline	C32H35N5O5	11250029	Moderate		Inter Info	[511]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[450], [451]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[514]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[515]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[16], [516]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[15]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[517]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[518]
D0885		Lacosamide	C13H18N2O3	219078	Moderate		Inter Info	[15], [16], [519]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[520]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[20], [15], [16], [448], [449]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[521], [522]
D1101		Naldemedine	C32H34N4O6	54732242	Moderate		Inter Info	[16], [523]
D1191		Ospemifene	C24H23ClO2	3036505	Moderate		Inter Info	[524]
D1221		Panobinostat	C21H23N3O2	6918837	Moderate		Inter Info	[525], [526]
D1227		Paritaprevir	C40H43N7O7S	45110509	Moderate		Inter Info	[16], [47], [527]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[15], [16], [529]
D1367		Quazepam	C17H11ClF4N2S	4999	Moderate		Inter Info	[21], [22], [427]
D1387		Regorafenib	C21H15ClF4N4O3	11167602	Moderate		Inter Info	[15], [18], [530]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[534]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[15], [16], [535]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[15], [16], [536]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[537]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[538]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[16], [539]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[16], [17], [540]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[541]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[16], [543]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[15], [544], [18]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[545]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[546]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[547]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[207], [548], [219]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[552]
D0713		Gefitinib	C22H24ClFN4O3	123631	Moderate		Inter Info	[482], [553]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[21], [22], [427]
D0748		Halazepam	C17H12ClF3N2O	31640	Moderate		Inter Info	[21], [22], [427]
D0774		Hydrocortisone (ophthalmic)	C21H30O5	5754	Moderate		Inter Info	[69], [455], [214]
D0790		Ifosfamide	C7H15Cl2N2O2P	3690	Moderate		Inter Info	[21], [22], [427]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[434], [435], [436], [437], [438], [439], [440], [21], [22], [49], [441], [442], [443], [444], [445], [446], [447]
D0865		Isradipine	C19H21N3O5	3784	Moderate		Inter Info	[21], [22], [427]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[554], [21], [22]
D0870		Ivermectin	C48H74O14	6321424	Moderate		Inter Info	[16], [555]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[554], [21], [22]
D0916		Levobupivacaine	C18H28N2O	92253	Moderate		Inter Info	[16], [556]
D0955		Loteprednol (ophthalmic)	C21H27ClO5	9865442	Moderate		Inter Info	[69], [455], [214]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[557], [558], [255], [559], [560]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[342], [490], [491], [492], [493], [345], [226]
D1130		Nicardipine	C26H29N3O6	4474	Moderate		Inter Info	[21], [22], [427]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[21], [22], [427]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[21], [22], [427]
D1141		Nisoldipine	C20H24N2O6	4499	Moderate		Inter Info	[21], [22], [427]
D1226		Paricalcitol	C27H44O3	5281104	Moderate		Inter Info	[16], [567]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[303], [188], [65], [453], [454], [69], [17], [455], [456], [304], [195], [196], [457], [305], [306], [307], [458], [72], [459], [77], [78], [214], [460], [308], [309], [461], [462], [463], [221]
D1333		Prednisolone (ophthalmic)	C21H28O5	5755	Moderate		Inter Info	[69], [455], [214]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[303], [188], [65], [453], [454], [69], [17], [455], [456], [304], [195], [196], [457], [305], [306], [307], [458], [72], [459], [77], [78], [214], [460], [308], [309], [461], [462], [463], [221]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[568], [569]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[15], [16], [570], [571], [572], [573], [574], [575], [576], [577], [578]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[579]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[588], [589], [15], [16], [590], [591], [592], [21], [593]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[594], [595], [135]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[15], [18], [596]
D1527		Tadalafil	C22H19N3O4	110635	Moderate		Inter Info	[597], [598], [343], [599], [44], [46], [467], [22], [48], [49], [50]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[600], [601]
D1558		Testosterone	C19H28O2	6013	Moderate		Inter Info	[21], [22], [427]
D1559		Testosterone (topical)	C19H28O2	6013	Moderate		Inter Info	[21], [22]
D1578		Tiagabine	C20H25NO2S2	60648	Moderate		Inter Info	[21], [22], [427]
D1607		Tolterodine	C22H31NO	443879	Moderate		Inter Info	[602], [603]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[604], [605], [606], [607], [608], [21], [44], [609], [22], [47], [610], [48], [49], [501], [50]
D1626		Tretinoin	C20H28O2	444795	Moderate		Inter Info	[611], [612], [613], [614], [615], [616], [617], [618], [619], [620], [621]
D1629		Triamcinolone (nasal)	C21H27FO6	31307	Moderate		Inter Info	[69], [455], [214]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[69], [455], [214]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[622], [427]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[15], [16], [623]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[21], [22], [427]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[16], [361]
D0345		Citalopram	C20H21FN2O	2771	Minor		Inter Info	[624], [625]
D0349		Clarithromycin	C38H69NO13	84029	Minor		Inter Info	[554], [21], [481]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[626], [255], [627], [628]
D0599		Escitalopram	C20H21FN2O	146570	Minor		Inter Info	[624], [625]
D0007		Abiraterone	C24H31NO	132971	Minor		Inter Info	[629]
D0053		Ambrisentan	C22H22N2O4	6918493	Minor		Inter Info	[630]
D0248		Cannabidiol	C21H30O2	644019	Minor		Inter Info	[16], [631]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[632]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[633]
D0589		Eravacycline	C27H31FN4O8	54726192	Minor		Inter Info	[634]
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Minor		Inter Info	[635]
D0797		Indacaterol	C24H28N2O3	6918554	Minor		Inter Info	[636]
D1074		Mirabegron	C21H24N4O2S	9865528	Minor		Inter Info	[637]
D1127		Netupitant	C30H32F6N4O	6451149	Minor		Inter Info	[635]
D1653		Troleandomycin	C41H67NO15	202225	Minor		Inter Info	[554], [21], [481]
D1664		Ulipristal	C28H35NO3	13559281	Minor		Inter Info	[16], [638]
D0799		Indinavir	C36H47N5O4	5362440	Minor		Inter Info	[21], [22]
D1117		Nefazodone	C25H32ClN5O2	4449	Minor		Inter Info	[554], [21], [481]
D1119		Nelfinavir	C32H45N3O4S	64143	Minor		Inter Info	[21], [22]
D1291		Pimecrolimus (topical)	C43H68ClNO11	6509979	Minor		Inter Info	[639]
D1394		Retapamulin (topical)	C30H47NO4S	6918462	Minor		Inter Info	[640]
D1428		Ropivacaine	C17H26N2O	175805	Minor		Inter Info	[641], [642], [643], [644], [645], [646], [647]
D1726		Ziprasidone	C21H21ClN4OS	60854	Minor		Inter Info	[648], [649], [650], [651]
	CYP450 enzyme induction					Drug Num: 42
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0515		Dolutegravir	C20H19F2N3O5	54726191	Major		Inter Info	[168], [169]
D0711		Garlic	NA	NA	Major		Inter Info	[223], [224], [225], [226]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[237]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[15], [275], [16], [47]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[339], [22], [340]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[341], [342], [20], [15], [16], [21], [343], [44], [45], [46], [22], [48], [344], [49], [50], [345], [346], [226]
D0061		Aminoglutethimide	C13H16N2O2	2145	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0178		Bexarotene	C24H28O2	82146	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[479], [21], [22], [480], [481]
D0639		Felbamate	C11H14N2O4	3331	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[342], [490], [491], [492], [493], [345], [226]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[342], [431], [433], [512], [513], [22], [345], [226]
D0905		Lesinurad	C17H14BrN3O2S	53465279	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[16], [528]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[49], [345], [226]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[16], [542]
D0741		Griseofulvin	C17H17ClO6	441140	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[49], [345], [226]
D1078		Mitotane	C14H10Cl4	4211	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1099		Nafcillin	C21H22N2O5S	8982	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[341], [561], [60], [562], [563], [564], [21], [22], [504], [565], [226]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[342], [431], [433], [512], [513], [22], [345], [226]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[580], [581], [582], [583], [584], [21], [44], [320], [45], [22], [47], [585], [49], [50], [586], [587]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[49], [345], [226]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[341], [342], [431], [20], [432], [433], [21], [343], [44], [45], [46], [22], [48], [49], [50], [345], [226]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antidiabetic agents					Drug Num: 36
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0009		Acarbose	C25H43NO18	41774	Moderate		Inter Info	[424], [425], [426]
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[424], [425], [426]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[424], [425], [426]
D0029		Albiglutide	C148H224N40O45	145994868	Moderate		Inter Info	[424], [425], [426]
D0042		Alogliptin	C18H21N5O2	11450633	Moderate		Inter Info	[424], [425], [426]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[424], [425], [426]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[424], [425], [426]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[424], [425], [426]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Moderate		Inter Info	[424], [425], [426]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[424], [425], [426]
D0936		Liraglutide	C172H265N43O51	16134956	Moderate		Inter Info	[424], [425], [426]
D0941		Lixisenatide	C215H347N61O65S	90472060	Moderate		Inter Info	[424], [425], [426]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[424], [425], [426]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[424], [425], [426]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[424], [425], [426]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[424], [425], [426]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[424], [425], [426]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[424], [425], [426]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[424], [425], [426]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[424], [425], [426]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[424], [425], [426]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[424], [425], [426]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[424], [425], [426]
D1064		Miglitol	C8H17NO5	441314	Moderate		Inter Info	[424], [425], [426]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[424], [425], [426]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[424], [425], [426]
D1326		Pramlintide	C171H267N51O53S2	70691388	Moderate		Inter Info	[424], [425], [426]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[424], [425], [426]
D1477		Sitagliptin	C16H15F6N5O	4369359	Moderate		Inter Info	[424], [425], [426]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[424], [425], [426]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[424], [425], [426]
	Antagonize the effect of antihypertensive agents					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1779		Dulaglutide	NA	NA	Moderate		Inter Info	[424], [425], [426]
D1782		Ertugliflozin	C22H25ClO7	44814423	Moderate		Inter Info	[424], [425], [426]
D1887		Semaglutide	C187H291N45O59	56843331	Moderate		Inter Info	[424], [425], [426]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1444		Saquinavir	C38H50N6O5	441243	Minor		Inter Info	[16], [21], [22]

References
1	Bartkowski RR, Goldberg ME, Larijani GE, Boerner T "Inhibition of alfentanil metabolism by erythromycin." Clin Pharmacol Ther 46 (1989): 99-102. [PMID: 2501060]
2	Bartkowski RR, McDonnell TE "Prolonged alfentanil effect following erythromycin administration." Anesthesiology 73 (1990): 566-8. [PMID: 2203286]
3	Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
4	Kharasch ED, Walker A, Hoffer C, Sheffels P "Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis." Clin Pharmacol Ther 76 (2004): 452-66. [PMID: 15536460]
5	Klees TM, Sheffels P, Dale O, Kharasch ED "Metabolism of alfentanil by cytochrome P4503A enzymes." Drug Metab Dispos 33 (2005): 303-11. [PMID: 15557344]
6	Klees TM, Sheffels P, Thummel KE, Kharasch ED "Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5." Anesthesiology 102 (2005): 550-556. [PMID: 15731592]
7	Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
8	Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
9	Palkama VJ, Isohanni MH, Neuvonen PJ, Olkkola KT "The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil." Anesth Analg 87 (1998): 190-4. [PMID: 9661572]
10	Product Information. Alfenta (alfentanil). Janssen Pharmaceutica, Titusville, NJ.
11	Yate PM, Thomas D, Short SM, Sebel PS, Morton J "Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU." Br J Anaesth 58 (1986): 1091-9. [PMID: 2876719]
12	Yun CH, Wood M, Wood AJ, Guengerich FP "Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4: an explanation of the variable elimination clearance." Anesthesiology 77 (1992): 467-74. [PMID: 1519785]
13	Ibrahim AE, Feldman J, Karim A, Kharasch ED "Simultaneous Assessment of Drug Interactions with Low- and High-Extraction Opioids: Application to Parecoxib Effects on the Pharmacokinetics and Pharmacodynamics of Fentanyl and Alfentanil." Anesthesiology 98 (2003): 853-861. [PMID: 12657846]
14	Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
15	Cerner Multum, Inc. "Australian Product Information.".
16	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
17	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
18	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
19	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
20	Canadian Pharmacists Association.
21	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
22	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
23	Ament PW, Paterson A "Drug interactions with the nonsedating antihistamines." Am Fam Physician 56 (1997): 223. [PMID: 9225677]
24	Biglin KE, Faraon MS, Constance TD, Lieh-Lai M "Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin." Ann Pharmacother 28 (1994): 282. [PMID: 8173153]
25	Craft TM "Torsade de pointes after astemizole overdose." Br Med J 292 (1986): 660. [PMID: 2868774]
26	Crane JK, Shih HT "Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine." Am J Med 95 (1993): 445-6. [PMID: 8213879]
27	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
28	DuBuske LM "Second-generation antihistamines: the risk of ventricular arrhythmias." Clin Ther 21 (1999): 281-95. [PMID: 10211532]
29	Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences [published correction appears in JAMA 1993 Apr 28;269(16):2088]. JAMA. 1993;269(12):1513-1518. [PMID: 8445813]
30	Gonzalez MA, Estes KS "Pharmacokinetic overview of oral second-generation H-1 antihistamines." Int J Clin Pharmacol Ther 36 (1998): 292-300. [PMID: 9629995]
31	Hasan RA, Zureikat GY, Nolan BM "Torsade de pointes associated with astemizole overdose treated with magnesium sulfate." Pediatr Emerg Care 9 (1993): 23-5. [PMID: 8488140]
32	Heidemann SM, Sarnaik AP "Arrhythmias after astemizole overdose." Pediatr Emerg Care 12 (1996): 102-4. [PMID: 8859918]
33	Hey JA, Delprado M, Egan RW, Kreutner W "Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects." Ann Allergy Asthma Immunol 76 (1996): 476. [PMID: 8630724]
34	Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr "Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin." Clin Pharmacol Ther 52 (1992): 231-8. [PMID: 1526078]
35	Honig PK, Wortham DC, Hull R, Zamani K, Smith JE, Cantilena LR "Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics." J Clin Pharmacol 33 (1993): 1201-6. [PMID: 8126255]
36	Honig PK, Wortham DC, Zamani K, et al "Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences." JAMA 269 (1993): 1513-8. [PMID: 8445813]
37	Jurima-Romet M, Crawford K, Cyr T, Inaba T "Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals." Drug Metab Dispos 22 (1994): 849-57. [PMID: 7895601]
38	Kivisto KT, Neuvonen PJ, Klotz U "Inhibition of terfenadine metabolism - pharmacokinetic and pharmacodynamic consequences." Clin Pharmacokinet 27 (1994): 1-5. [PMID: 7955768]
39	Mangum EM, Graham KK "Lopinavir-Ritonavir: a new protease inhibitor." Pharmacotherapy 21 (2001): 1352-63. [PMID: 11714208]
40	Mathews DR, McNutt B, Okerholm R, et al "Torsades de pointes occurring in association with terfenadine use." JAMA 266 (1991): 2375-6. [PMID: 1920744]
41	Ng PW, Chan WK, Chan TYK "Torsade de pointes during the concomitant use of terfenadine and cimetidine." Aust N Z J Med 26 (1996): 120-1. [PMID: 8775544]
42	Paris DG, Parente TF, Bruschetta HR, Guzman E, Niarchos AP "Torsades-de-pointes induced by erythromycin and terfenadine." Am J Emerg Med 12 (1994): 636-8. [PMID: 7945604]
43	Pohjola-Sintonen S, Viitasalo M, Toivonene L, Neuvonen P "Torsades de pointes after terfenadine-itraconazole interaction." BMJ 306 (1993): 186. [PMID: 8382980]
44	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
45	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
46	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
47	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
48	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
49	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
50	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
51	Rankin AC "Non-sedating antihistamines and cardiac arrhythmia." Lancet 350 (1997): 1115-6. [PMID: 9343494]
52	Rao KA, Adlakha A, Vermaansil B, Meloy TD, Stanton MS "Torsades de pointes ventricular tachycardia associated with overdose of astemizole." Mayo Clin Proc 69 (1994): 589-93. [PMID: 8189766]
53	Saviuc P, Danel V, Dixmerias F "Prolonged QT interval and torsade de pointes following astemizole overdose." J Toxicol Clin Toxicol 31 (1993): 121-5. [PMID: 8433408]
54	Smith SJ "Cardiovascular toxicity of antihistamines." Otolaryngol Head Neck Surg 111 Suppl (1994): 348-54. [PMID: 7916150]
55	Snook J, Boothman-Burrell D, Watkins J, Colin-Jones D "Torsade de pointes ventricular tachycardia associated with astemizole overdose." Br J Clin Pract 42 (1988): 257-9. [PMID: 2905156]
56	Tsai WC, Tsai LM, Chen JH "Combined use of astemizole and ketoconazole resulting in torsade de pointes." J Formos Med Assoc 96 (1997): 144-6. [PMID: 9071844]
57	Vorperian VR, Zhou ZF, Mohammad S, Hoon TJ, Studenik C, January CT "Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole." J Am Coll Cardiol 28 (1996): 1556-61. [PMID: 8917271]
58	Woosley RL "Cardiac actions of antihistamines." Annu Rev Pharmacol Toxicol 36 (1996): 233-52. [PMID: 8725389]
59	Zimmermann M, Duruz H, Guinand O, et al "Torsades de Pointes after treatment with terfenadine and ketoconazole." Eur Heart J 13 (1992): 1002-3. [PMID: 1644069]
60	Barry M, Mulcahy F, Merry C, Gibbons S, Back D "Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection." Clin Pharmacokinet 36 (1999): 289-304. [PMID: 10320951]
61	Fichtenbaum CJ, Gerber JG, Rosenkranz SL, et al. "Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047." AIDS 16 (2002): 569-577. [PMID: 11873000]
62	Malaty LI, Kuper JJ "Drug interactions of HIV protease inhibitors." Drug Safety 20 (1999): 147-69. [PMID: 10082072]
63	Piliero PJ "Interaction between ritonavir and statins." Am J Med 112 (2002): 510-1. [PMID: 11959074]
64	US Food and Drug Administration "FACT SHEET FOR HEALTHCARE PROVIDERS EMERGENCY USE AUTHORIZATION FOR PAXLOVID.".
65	Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN "Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole." Ann Pharmacother 38 (2004): 46-9. [PMID: 14742792]
66	Daveluy A, Raignoux C, Miremont-Salame G, et al. "Drug interactions between inhaled corticosteroids and enzymatic inhibitors." Eur J Clin Pharmacol (2009):. [PMID: 19399485]
67	De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J "Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450." J Calif Dent Assoc 2 (2003): 72-5. [PMID: 15463853]
68	De Wachter E, Vanbesien J, De Schutter I, Malfroot A, De Schepper J "Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide." Eur J Pediatr (2003):. [PMID: 12719971]
69	Edsbacker S, Andersson T "Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease." Clin Pharmacokinet 43 (2004): 803-21. [PMID: 15355126]
70	Jonsson G, Astrom A, Andersson P "Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver." Drug Metab Dispos 23 (1995): 137-42. [PMID: 7720517]
71	Kedem E, Shahar E, Hassoun G, Pollack S "Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient." J Asthma 47 (2010): 830-1. [PMID: 20653496]
72	Main KM, Skov M, Sillesen IB, et al. "Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient." Acta Paediatr 91 (2002): 1008-11. [PMID: 12412882]
73	Molimard M, Girodet PO, Pollet C, et al. "Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation." Drug Saf 31 (2008): 769-74. [PMID: 18707191]
74	Product Information. Entocort (budesonide). AstraZeneca Pharma Inc, Mississauga, ON.
75	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
76	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
77	Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivisto KT "Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole." Clin Pharmacol Ther 72 (2002): 362-369. [PMID: 12386638]
78	Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S "Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide." Eur Respir J 20 (2002): 127-33. [PMID: 12166560]
79	Product Information. Pletal (cilostazol). Otsuka American Pharmaceuticals, Rockville, MD.
80	Suri A, Bramer SL "Effect of omeprazole on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 53-9. [PMID: 10702887]
81	Suri A, Forbes WP, Bramer SL "Effects of CYP3A inhibition on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 61-8. [PMID: 10702888]
82	Bran S, Murray WA, Hirsch IB, Palmer JP "Long QT syndrome during high-dose cisapride." Arch Intern Med 155 (1995): 765-8. [PMID: 7695465]
83	Desta Z, Soukhova N, Mahal SK, Flockhart DA "Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies." Drug Metab Dispos 28 (2000): 789-800. [PMID: 10859153]
84	Gill J, Feinberg J "Saquinavir soft gelatin capsule - A comparative safety review." Drug Safety 24 (2001): 223-32. [PMID: 11347724]
85	Gray VS "Syncopal episodes associated with cisapride and concurrent drugs." Ann Pharmacother 32 (1998): 648-51. [PMID: 9640482]
86	Hill SL, Evangelista JK, Pizzi AM, Mobassaleh M, Fulton DR, Berul CI "Proarrhythmia associated with cisapride in children." Pediatrics 101 (1998): 1053-6. [PMID: 9606235]
87	Lewin MB, Bryant RM, Fenrich AL, Grifka RG "Cisapride-induced long QT interval." J Pediatr 128 (1996): 279-81. [PMID: 8636830]
88	Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
89	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
90	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
91	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
92	Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
93	Brinkman K, Huysmans F, Burger DM "Pharmacokinetic interaction between saquinavir and cyclosporine." Ann Intern Med 129 (1998): 914-5. [PMID: 9867740]
94	Product Information. Neoral Soft Gelatin Capsules (cyclosporine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
95	Niwa T, Shiraga T, Takagi A "Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, CYP3A4 activities in human liver microsomes." Biol Pharm Bull 28 (2005): 1805-8. [PMID: 16141567]
96	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
97	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
98	Tran JQ, Petersen C, Garrett M, Hee B, Kerr BM "Pharmacokinetic interaction between amprenavir and delavirdine: Evidence of induced clearance by amprenavir." Clin Pharmacol Ther 72 (2002): 615-26. [PMID: 12496743]
99	Bailey DG, Arnold JMO, Spence JD "Grapefruit juice and drugs - how significant is the interaction." Clin Pharmacokinet 26 (1994): 91-8. [PMID: 8162660]
100	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
101	Baldwin ZK, Ceraldi CC "Ergotism associated with HIV antiviral protease inhibitor therapy." J Vasc Surg 37 (2003): 676-8. [PMID: 12618710]
102	Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D "Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir." Postgrad Med J 75 (1999): 546-7. [PMID: 10616689]
103	Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes LF "Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient." Antimicrob Agents Chemother 41 (1997): 1207. [PMID: 9145904]
104	Eadie MJ "Clinically significant drug interactions with agents specific for migraine attacks." Cns Drugs 15 (2001): 105-18. [PMID: 11460889]
105	Liaudet L "Severe ergotism associated with interaction between ritonavir and ergotamine." BMJ 318 (1999): 771. [PMID: 10082701]
106	Liaudet L, Buclin T, Jaccard C, Eckert P "Severe ergotism associated with interaction between ritonavir and ergotamine." Br Med J 318 (1999): 771. [PMID: 10082701]
107	Montero A, Giovannoni AG, Tvrde PL "Leg ischemia in a patient receiving ritonavir and ergotamine." Ann Intern Med 130 (1999): 329. [PMID: 10068398]
108	Mortier E, Pouchet J, Vinceneux P, Lalande M "Ergotism related to interaction between nelfinavir and ergotamine." Am J Med 110 (2001): 594. [PMID: 11347624]
109	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
110	Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
111	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
112	Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP "Ergotism related to concurrent administration of ergotamine tartrate and indinavir." JAMA 281 (1999): 987. [PMID: 10086430]
113	Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W "Cerebral ergotism under treatment with ergotamine and ritonavir." Neurology 57 (2001): 743-4. [PMID: 11524501]
114	Srisuma S, Lavonas EJ, Wananukul W "Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors." Clin Toxicol (Phila) (2014): 1-4. [PMID: 24978905]
115	Tribble MA, Gregg CR, Margolis DM, Amirkhan R, Smith JW "Fatal ergotism induced by an HIV protease inhibitor." Headache 42 (2002): 694-5. [PMID: 12482227]
116	Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F "Clinical ergotism induced by ritonavir." Scand J Infect Dis 33 (2001): 788-9. [PMID: 11728055]
117	Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
118	Engels FK, Mathot RA, Loos WJ, van Schaik RH, Verweij J "Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel." Cancer Biol Ther 5 (2006): 833-9. [PMID: 16775418]
119	McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
120	Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
121	Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
122	Vodovar D, Arnaout M, Mongardon N, et al. "Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone." J Clin Oncol 29 (2011): e694-5. [PMID: 21730272]
123	Yong WP, Wang LZ, Tham LS, et al. "A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers." Cancer Chemother Pharmacol 62 (2008): 243-51. [PMID: 17909805]
124	Product Information. Relpax (eletriptan). Pfizer U.S. Pharmaceuticals, New York, NY.
125	Product Information. Inspra (eplerenone). Searle, Chicago, IL.
126	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
127	Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM "Oral erythromycin and the risk of sudden death from cardiac causes." N Engl J Med 351 (2004): 1089-96. [PMID: 15356306]
128	Alderman CP, Gebauer MG, Gilbert AL, Condon JT "Possible interaction of zopiclone and nefazodone." Ann Pharmacother 35 (2001): 1378-80. [PMID: 11724087]
129	Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Bretano C, Jaillon P "Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism." Drug Metab Dispos 27 (1999): 1068-73. [PMID: 10460808]
130	Product Information. Imovane (zopiclone). Rhone-Poulenc Rorer Canada Inc, Laval, IN.
131	Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
132	Labroo RB, Paine MF, Thummel KE, Kharasch ED "Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implicaitons for interindividual variability in disposition, efficacy, and drug interactions." Drug Metab Dispos 25 (1997): 1072-80. [PMID: 9311623]
133	Product Information. Actiq (fentanyl). Abbott Pharmaceutical, Abbott Park, IL.
134	Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
135	Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP, Wood M "Identification of human cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation." Anesth Analg 82 (1996): 167-72. [PMID: 8712396]
136	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
137	Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
138	Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
139	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
140	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
141	Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA "CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes." Br J Clin Pharmacol 57 (2004): 287-97. [PMID: 14998425]
142	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
143	Vizcaychipi MP, Walker S, Palazzo M "Serotonin syndrome triggered by tramadol." Br J Anaesth 99 (2007): 919. [PMID: 18006535]
144	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
145	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
146	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
147	Product Information. Vraylar (cariprazine). Actavis Pharma, Inc., Parsippany, NJ.
148	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
149	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
150	Akdag I, Ersoy A, Kahvecioglu S, Gullulu M, Dilek K "Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure." J Nephrol 19 (2006): 515-7. [PMID: 17048210]
151	Boomershine KH "Colchicine-induced rhabdomyolysis." Ann Pharmacother 36 (2002): 824-6. [PMID: 11978160]
152	Caraco Y, Putterman C, Rahamimov R, Ben-Chetrit E "Acute colchicine intoxication: possible role of erythromycin administration." J Rheumatol 19 (1992): 494-6. [PMID: 1578471]
153	Cheng VC, Ho PL, Yuen KY "Two probable cases of serious drug interaction between clarithromycin and colchicine." South Med J 98 (2005): 811-3. [PMID: 16144178]
154	Colchicine: serious interactions. Prescrire Int 17 (2008): 151-3. [PMID: 19492485]
155	Dogukan A, Oymak FS, Taskapan H, Guven M, Tokgoz B, Utas C "Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration." Clin Nephrol 55 (2001): 181-2. [PMID: 11269688]
156	Hung IF, Wu AK, Cheng VC, et al. "Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study." Clin Infect Dis 41 (2005): 291-300. [PMID: 16007523]
157	McKinnell J, Tayek JA "Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis." J Clin Rheumatol 15 (2009): 303-5. [PMID: 19734738]
158	Product Information. Colcrys (colchicine). AR Scientific Inc, Philadelphia, PA.
159	Putterman C, Ben-Chetrit E, Caraco Y, Levy M "Colchicine intoxication: clinical pharmacology, risk factors, features, and management." Semin Arthritis Rheum 21 (1991): 143-55. [PMID: 1788551]
160	Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, Kelaidi C, Blanche P "Acute colchicine intoxication during clarithromycin administration." Ann Pharmacother 38 (2004): 2074-7. [PMID: 15494379]
161	Schiff D, Drislane FW "Rapid-onset colchicine myoneuropathy." Arthritis Rheum 35 (1992): 1535-6. [PMID: 1472131]
162	Severe colchicine-macrolide interactions. Prescrire Int 12 (2003): 18-9. [PMID: 12602385]
163	Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ "Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation." Biochem Pharmacol 53 (1996): 111-6. [PMID: 8960070]
164	van der Velden W, Huussen J, Ter Laak H, de Sevaux R "Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin." Neth J Med 66 (2008): 204-6. [PMID: 18490798]
165	Wilbur K, Makowsky M "Colchicine myotoxicity: case reports and literature review." Pharmacotherapy 24 (2004): 1784-92. [PMID: 15585444]
166	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
167	Product Information. Emflaza (deflazacort). Marathon Pharmaceuticals, Deerfield, IL.
168	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
169	Product Information. Triumeq (abacavir/dolutegravir/lamiVUDine). ViiV Healthcare, Research Triangle Park, NC.
170	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
171	Product Information. Prezcobix (cobicistat-darunavir). Janssen Pharmaceuticals, Titusville, NJ.
172	Product Information. Slynd (drospirenone). Exeltis USA, Inc., Chatham, NJ.
173	Product Information. Symtuza (cobicistat/darunavir/emtricitabine/tenof). Janssen Pharmaceuticals, Titusville, NJ.
174	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
175	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
176	Han TH, Gopal AK, Ramchandren R, et al. "CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies." J Clin Pharmacol 53 (2013): 866-77. [PMID: 23754575]
177	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
178	Product Information. Padcev (enfortumab vedotin). Seattle Genetics Inc, Bothell, WA.
179	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
180	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
181	Homma S, Takahashi KI, Nihei S, Kato F, Sugihara S, Nunoda S "The successful management of respiratory complications with long-term, low-dose macrolide administration in pediatric heart transplant recipients." Int Heart J (2014):. [PMID: 25297501]
182	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
183	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
184	Product Information. Sporonox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
185	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
186	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
187	Arrington-Sanders R, Hutton N, Siberry GK "Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents." Pediatr Infect Dis J 25 (2006): 1044-1048. [PMID: 17072128]
188	Bhumbra NA, Sahloff EG, Oehrtman SJ, Horner JM "Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir/ritonavir." Ann Pharmacother 41 (2007): 1306-9. [PMID: 17535841]
189	Boorsma M, Andersson N, Larsson P, Ullman A "Assessment of the relative systemic potency of inihaled fluticasone and budesonide." Eur Respir J 9 (1996): 1427-32. [PMID: 8836654]
190	Brus R "Effects of high-dose inhaled corticosteroids on plasma cortisol consentrations in healthy adults." Arch Intern Med 159 (1999): 1903-8. [PMID: 10493320]
191	Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ "Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate." Am J Respir Crit Care Med 170 (2004): 960-6. [PMID: 15184207]
192	Foisy MM, Yakiwchuk EM, Chiu I, Singh AE "Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature." HIV Med 9 (2008): 389-96. [PMID: 18459946]
193	Gillett MJ, Cameron PU, Nguyen HV, Hurley DM, Mallal SA "Iatrogenic Cushing's syndrome in an HIV-infected patient treated with ritonavir and inhaled fluticasone." AIDS 19 (2005): 740-1. [PMID: 15821405]
194	Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A "An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers." Br J Clin Pharmacol 38 (1994): 521-5. [PMID: 7888290]
195	Gupta SK, Dube MP "Exogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophy." Clin Infect Dis 35 (2002): E69-71. [PMID: 12203188]
196	Hillebrand-Haverkort ME, Prummel MF, ten Veen JH "Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone." AIDS 13 (1999): 1803. [PMID: 10509596]
197	Jinno S, Goshima C "Progression of Kaposi sarcoma associated with iatrogenic Cushing syndrome in a person with HIV/AIDS." AIDS Read 18 (2008): 100-4. [PMID: 18333287]
198	Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J "Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone." J Pediatr 148 (2006): 386-388. [PMID: 16615973]
199	Kelly HW "Comparison of inhaled corticosteroids." Ann Pharmacother 32 (1998): 220-32. [PMID: 9496409]
200	Li AM "Ritonavir and fluticasone: Beware of this potentially fatal combination." J Pediatr 148 (2006): 294-5. [PMID: 16615953]
201	Lipworth BJ "Systemic adverse effects of inhaled corticosteroid therapy - A systematic review and meta-analysis." Arch Intern Med 159 (1999): 941-55. [PMID: 10326936]
202	Naef R, Schmid C, Hofer M, Minder S, Speich R, Boehler A "Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients." Respiration 74 (2007): 418-22. [PMID: 17003527]
203	Nocent C, Raherison C, Dupon M, Taytard A "Unexpected effects of inhaled fluticasone in an HIV patient with asthma." J Asthma 41 (2004): 793-5. [PMID: 15641628]
204	Parmar JS, Howell T, Kelly J, Bilton D "Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis." Thorax 57 (2002): 749-50. [PMID: 12149540]
205	Pearce RE, Leeder JS, Kearns GL "Biotransformation of fluticasone: in vitro characterization." Drug Metab Dispos 34 (2006): 1035-40. [PMID: 16565171]
206	Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM "Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. case report and literature review." AIDS 21 (2007): 529-32. [PMID: 17301576]
207	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
208	Product Information. Flonase (fluticasone). Glaxo Wellcome, Research Triangle Park, NC.
209	Product Information. Flovent (fluticasone). Glaxo Wellcome, Research Triangle Park, NC.
210	Product Information. Veramyst (fluticasone nasal). GlaxoSmithKline, Research Triangle Park, NC.
211	Rouanet I, Peyriere H, Mauboussin JM, Vincent D "Cushing's syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone." HIV Med 4 (2003): 149-50. [PMID: 12702137]
212	Sastre J "Pharmacology of fluticasone propionate." J Investig Allergol Clin Immunol 7 (1997): 382-4. [PMID: 9416555]
213	Schmid C, Naef R, Speich R, Boehler A "Addition of inhaled fluticasone propionate to systemic immunosuppression after lung transplantation: Cushing's Syndrome in patients on itraconazole comedication." Transplantation 76 (2003): 263-4. [PMID: 12865822]
214	Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J "Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction." Intern Med J 35 (2005): 67-8. [PMID: 15667475]
215	Todd GR, Acerini CL, Ross-Russell, Zahra S, Warner JT, McCance D "Survey of adrenal crisis associated witwh inhaled corticosteroids in the United Kingdom." Arch Dis Child 87 (2002): 457-61. [PMID: 12456538]
216	Vassiliadi D, Tsagarakis S "Unusual causes of Cushing's syndrome." Arq Bras Endocrinol Metabol 51 (2007): 1245-52. [PMID: 18209862]
217	Woods DR, Arun CS, Corris PA, Perros P "Cushing's syndrome without excess cortisol." BMJ 332 (2006): 469-70. [PMID: 16497762]
218	Bernecker C, West TB, Mansmann G, Scherbaum WA, Willenberg HS "Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature." Exp Clin Endocrinol Diabetes 120 (2012): 125-7. [PMID: 22328106]
219	Kempsford R, Norris V, Siederer S "Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD." Pulm Pharmacol Ther 26 (2013): 256-64. [PMID: 23232038]
220	Lonnebo A, Grahnen A, Jansson B, Brundin RM, Lingandersson A, Eckernas SA "An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers." Eur J Clin Pharmacol 49 (1996): 459-63. [PMID: 8706770]
221	Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA "Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in HIV-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases." J Clin Endocrinol Metab 90 (2005): 4394-8. [PMID: 15755851]
222	Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM "Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature." J Int Assoc Physicians AIDS Care 8 (2009): 113-21. [PMID: 19270151]
223	Borek C "Garlic supplements and saquinavir." Clin Infect Dis 35 (2002): 343. [PMID: 12115105]
224	NIAID. National Institute of Allergy and Infectious Diseases "Garlic supplements can impede HIV medication.".
225	Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J "The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir." Clin Infect Dis 34 (2002): 234-238. [PMID: 11740713]
226	Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
227	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
228	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
229	Product Information. Fanapt (iloperidone). Vanda Pharmaceuticals Inc, Rockville, MD.
230	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
231	Product Information. Nourianz (istradefylline). Kyowa Kirin, Inc, Bedminster, NJ.
232	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
233	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
234	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
235	Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
236	Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
237	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
238	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
239	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
240	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
241	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
242	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
243	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
244	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
245	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
246	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
247	Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
248	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
249	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
250	Abbas R, Hug BA, Leister C, Burns J, Sonnichsen D "Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects." Br J Clin Pharmacol 71 (2011): 522-7. [PMID: 21395644]
251	Product Information. Nerlynx (neratinib). Puma Biotechnology, Inc., Los Angeles, CA.
252	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
253	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
254	Product Information. Olinvyk (oliceridine). Trevena Inc, Chesterbrook, PA.
255	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
256	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
257	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
258	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
259	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
260	Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
261	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
262	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
263	Product Information. Polivy (polatuzumab vedotin). Genentech, South San Francisco, CA.
264	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
265	Product Information. Gavreto (pralsetinib). Blueprint Medicines Corporation, Cambridge, MA.
266	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
267	Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
268	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
269	Product Information. Koselugo (selumetinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
270	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
271	Product Information. Olysio (simeprevir). Janssen Pharmaceuticals, Titusville, NJ.
272	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
273	Product Information. VESIcare (solifenacin). GlaxoSmithKline, Research Triangle Park, NC.
274	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
275	Cerner Multum, Inc. "Canadian Product Information.".
276	Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
277	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
278	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
279	Machiels JP, Staddon A, Herremans C, et al. "Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies." Cancer Chemother Pharmacol 74 (2014): 729-37. [PMID: 25100135]
280	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
281	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
282	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
283	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
284	Product Information. Zontivity (vorapaxar). Merck & Company Inc, Whitehouse Station, NJ.
285	Product Information. Oxbryta (voxelotor). Global Blood Therapeutics, Inc., South San Francisco, CA.
286	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
287	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
288	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
289	Baune B, Flinois JP, Furlan V, et al. "Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5." J Pharm Pharmacol 51 (1999): 419-26. [PMID: 10385214]
290	Charbit B, Becquemont L, Lepere B, Peytavin G, Funck-Bretano C "Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine." Clin Pharmacol Ther 72 (2002): 514-23. [PMID: 12426515]
291	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
292	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
293	Corona G, Vaccher E, Sandron S, et al. "Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma." Clin Pharmacol Ther 83 (2008): 601-6. [PMID: 17713471]
294	Phansalker S, Desai AA, Bell D, et al "High-priority drug-drug interactions for use in electronic health records." J Am Med Inform Assoc 19 (2012): 735-43. [PMID: 22539083]
295	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
296	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
297	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
298	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
299	Cheng CH, Miller C, Lowe C, Pearson VE "Rhabdomyolysis due to probable interaction between simvastatin and ritonavir." Am J Health Syst Pharm 59 (2002): 728-30. [PMID: 11977859]
300	Hare CB, Vu MP, Grunfeld C, Lampiris HW "Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death." Clin Infect Dis 35 (2002): E111-2. [PMID: 12410494]
301	Neuvonen PJ, Backman JT, Niemi M "Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin." Clin Pharmacokinet 47 (2008): 463-74. [PMID: 18563955]
302	Schmidt GA, Hoehns JD, Purcell JL, Friedman RL, Elhawi Y "Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir." J Am Board Fam Med 20 (2007): 411-6. [PMID: 17615423]
303	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
304	Glynn AM, Slaughter RL, Brass C, et al "Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion." Clin Pharmacol Ther 39 (1986): 654-9. [PMID: 3709030]
305	Kandrotas RJ, Slaughter RL, Brass C, Jusko WJ "Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol." Clin Pharmacol Ther 42 (1987): 465-70. [PMID: 3311551]
306	Kotlyar M, Brewer ER, Golding M, Carson SW "Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect." J Clin Psychopharmacol 23 (2003): 652-6. [PMID: 14624194]
307	LaForce CF, Szefler SJ, Miller MF, Ebling W, Brenner M "Inhibition of methylprednisolone elimination in the presence of erythromycin therapy." J Allergy Clin Immunol 72 (1983): 34-9. [PMID: 6602160]
308	Varis T, Backman JT, Kivisto KT, Neuvonen PJ "Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone." Clin Pharmacol Ther 67 (2000): 215-21. [PMID: 10741623]
309	Varis T, Kaukonen KM, Kivisto KT, Neuvonen PJ "Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole." Clin Pharmacol Ther 64 (1998): 363-8. [PMID: 9797792]
310	Decker CJ, Laitinen LM, Bridson GW, Raybuck SA, Tung RD, Chaturvedi PR "Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions." J Pharm Sci 87 (1998): 803-7. [PMID: 9649346]
311	Eagling VA, Back DJ, Barry MG "Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir." Br J Clin Pharmacol 44 (1997): 190-4. [PMID: 9278209]
312	Greenblatt DJ, von Moltke LL, Harmatz JS, et al. "Differential impairment of triazolam and zolpidem clearance by ritonavir." J Acquir Immune Defic Syndr 24 (2000): 129-36. [PMID: 10935688]
313	Merry C, Mulcahy F, Barry M, Gibbons S, Back D "Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease." AIDS 11 (1997): 268-9. [PMID: 9030388]
314	Palkama VJ, Ahonen J, Neuvonen PJ, Olkkola KT "Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam." Clin Pharmacol Ther 66 (1999): 33-9. [PMID: 10430107]
315	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
316	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
317	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
318	Bundow D, Aboulafia DM "Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma." Am J Clin Oncol 27 (2004): 81-4. [PMID: 14758138]
319	Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scad "Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma." J Clin Oncol 17 (1999): 1876-83. [PMID: 10561228]
320	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
321	Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
322	Schwartz JD "Potential interaction of antriretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma." AIDS 13 (1999): 283-4. [PMID: 10202837]
323	Panday VRN, Hoetelmans RMW, vanHeeswijk RPG, Meenhorst PL, Inghels M, Mulder JW, Beijnen JH "Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma - drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study." Cancer Chemother Pharmacol 43 (1999): 516-9. [PMID: 10321513]
324	Desta Z, Kerbusch T, Flockhart DA "Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)." Clin Pharmacol Ther 65 (1999): 10-20. [PMID: 9951426]
325	Flockhart DA, Drici MD, Kerbusch T, et al "Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with tourette syndrome." J Clin Psychopharmacol 20 (2000): 317-24. [PMID: 10831018]
326	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
327	Krahenbuhl S, Sauter B, Kupferschmidt H, Krause M, Wyss PA, Meier PJ "Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication." Am J Med Sci 309 (1995): 315-6. [PMID: 7771501]
328	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
329	DeVane CL, Nemeroff CB "Clinical pharmacokinetics of quetiapine - An atypical antipsychotic." Clin Pharmacokinet 40 (2001): 509-22. [PMID: 11510628]
330	Geraci MJ, McCoy SL, Crum PM, Patel RA "Antipsychotic-induced priapism in an HIV patient: a cytochrome P450-mediated drug interaction." Int J Emerg Med 3 (2010): 81-4. [PMID: 20606815]
331	Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB "Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics." Br J Clin Pharmacol 61 (2006): 58-69. [PMID: 16390352]
332	Hantson P, Di Fazio V, Wallemacq P "Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose." Drug Metab Lett 4 (2010): 7-8. [PMID: 20201782]
333	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
334	Spina E, de Leon J "Metabolic drug interactions with newer antipsychotics: a comparative review." Basic Clin Pharmacol Toxicol 100 (2007): 4-22. [PMID: 17214606]
335	Spina E, Scordo MG, D'Arrigo C "Metabolic drug interactions with new psychotropic agents." Fundam Clin Pharmacol 17 (2003): 517-38. [PMID: 14703714]
336	Urichuk L, Prior TI, Dursun S, Baker G "Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions." Curr Drug Metab 9 (2008): 410-8. [PMID: 18537577]
337	Schulz-Du Bois C, Schulz-Du Bois AC, Bewig B, et al. "Major increase of quetiapine steady-state plasma concentration following co-administration of clarithromycin: confirmation of the pharmacokinetic interaction potential of quetiapine." Pharmacopsychiatry 41 (2008): 258-9. [PMID: 19067264]
338	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
339	McGregor MM, Olliaro P, Wolmarans L, Mabuza B, Bredell M, Felten MK, Fourie PB "Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis." Am J Respir Crit Care Med 154 (1996): 1462-7. [PMID: 8912765]
340	Veldkamp AI, Hoetelmans RM, Beijnen JH, Mulder JW, Meenhorst PL "Ritonavir enables combined therapy with rifampin and saquinavir." Clin Infect Dis 29 (1999): 1586. [PMID: 10585827]
341	Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12. [PMID: 10391416]
342	Barry M, Gibbons S, Back D, Mulcahy F "Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations." Clin Pharmacokinet 32 (1997): 194-209. [PMID: 9084959]
343	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
344	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
345	Sommadossi JP "HIV protease inhibitors: pharmacologic and metabolic distinctions." AIDS 13 (1999): s29-40. [PMID: 10546783]
346	Temple ME, Nahata MC "Rifapentine: its role in the treatment of tuberculosis." Ann Pharmacother 33 (1999): 1203-10. [PMID: 10573321]
347	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
348	Hall MCS, Ahmad S "Interaction between sildenafil and HIV-1 combination therapy." Lancet 353 (1999): 2071-2. [PMID: 10376645]
349	Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
350	Merry C, Barry MG, Ryan M, Tjia JF, Hennessy M, Eagling VA, Mulcahy F, Back DJ "Interaction of sildenafil and indinavir when co-administered to HIV-positive patients." AIDS 13 (1999): f101-7. [PMID: 10546851]
351	Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N "Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir." Br J Clin Pharmacol 50 (2000): 99-107. [PMID: 10930961]
352	Nandwani R, Gourlay Y "Possible interaction between sildenafil and HIV combination therapy." Lancet 353 (1999): 840. [PMID: 10459981]
353	Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
354	Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
355	Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
356	Claesson K, Brattstrom C, Burke JT "Sirolimus and erythromycin interaction: two cases." Transplant Proc 33 (2001): 2136. [PMID: 11377477]
357	Dodds-Ashley E "Management of drug and food interactions with azole antifungal agents in transplant recipients." Pharmacotherapy 30 (2010): 842-54. [PMID: 20653361]
358	Floren LC, Christians U, Zimmerman JJ, et al "Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole." Clin Pharmacol Ther 65 (1999): 159.
359	Product Information. Noxafil (posaconazole). Schering-Plough Corporation, Kenilworth, NJ.
360	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
361	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
362	Barau C, Blouin P, Creput C, Taburet AM, Durrbach A, Furlan V "Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient." Fundam Clin Pharmacol 23 (2009): 423-5. [PMID: 19709321]
363	Cakaloglu Y, Tredger JM, Devlin J, Williams R "Importance of cytochrome p-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients." Hepatology 20 (1994): 309-16. [PMID: 7519161]
364	Jain AB, Venkataramanan R, Eghtesad B, et al. "Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients." Liver Transpl 9 (2003): 954-60. [PMID: 12942457]
365	Jain AK, Venkataramanan R, Shapiro R, et al. "Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients." Transplant Proc 34 (2002): 1540-1. [PMID: 12176474]
366	Jain AK, Venkataramanan R, Shapiro R, et al. "The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients." Liver Transpl 8 (2002): 841-5. [PMID: 12200788]
367	Mertz D, Battegay M, Marzolini C, Mayr M "Drug-Drug Interaction in a Kidney Transplant Recipient Receiving HIV Salvage Therapy and Tacrolimus." Am J Kidney Dis (2009):. [PMID: 19346040]
368	Pea F, Tavio M, Pavan F, et al. "Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients." Antivir Ther 13 (2008): 739-42. [PMID: 18771060]
369	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
370	Schonder KS, Shullo MA, Okusanya O "Tacrolimus and lopinavir/ritonavir interaction in liver transplantation." Ann Pharmacother 37 (2003): 1793-6. [PMID: 14632538]
371	Tsapepas DS, Webber AB, Aull MJ, Figueiro JM, Saal SD "Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient." Am J Health Syst Pharm 68 (2011): 138-42. [PMID: 21200061]
372	Teicher E, Vincent I, Bonhomme-Faivre L, et al. "Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study." Clin Pharmacokinet 46 (2007): 941-52. [PMID: 17922559]
373	Franco-Salinas G, de la Rosette JJ, Michel MC "Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations." Clin Pharmacokinet 49 (2010): 177-88. [PMID: 20170206]
374	Kamimura H, Oishi S, Matsushima H, et al. "Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes." Xenobiotica 28 (1998): 909-22. [PMID: 9849639]
375	Product Information. Flomax (tamsulosin). Boehringer-Ingelheim, Ridgefield, CT.
376	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
377	Albert NE, Kazi S, Santoro J, Dougherty R "Ritonavir and Epidural Triamcinolone as a Cause of Iatrogenic Cushing's Syndrome." Am J Med Sci (2012):. [PMID: 22543594]
378	Dort K, Padia S, Wispelwey B, Moore CC "Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report." AIDS Res Ther 6 (2009): 10. [PMID: 19505306]
379	Fessler D, Beach J, Keel J, Stead W "Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors." Pain Physician 15 (2012): 489-93. [PMID: 23159966]
380	Hagan JB, Erickson D, Singh RJ "Triamcinolone Acetonide Induced Secondary Adrenal Insufficiency Related to Impaired CYP3A4 Metabolism by Coadministration of Nefazodone." Pain Med (2010):. [PMID: 20456080]
381	Hall JJ, Hughes CA, Foisy MM, Houston S, Shafran S "Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir boosted darunavir." Int J STD AIDS (2013):. [PMID: 23970582]
382	Levine D, Ananthakrishnan S, Garg A "Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy." J Am Acad Dermatol 65 (2011): 877-8. [PMID: 21920248]
383	McConkey HZ, Williams H, Kulasegaram R, Graham E "Orbital floor triamcinolone causing Cushing's syndrome in a patient treated with Kaletra for HIV 1." BMJ Case Rep 2013 (2013):. [PMID: 23440982]
384	Sadarangani S, Berg ML, Mauck W, Rizza S "Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review." Interdiscip Perspect Infect Dis 2014 (2014): 849432. [PMID: 24895495]
385	Schwarze-Zander C, Klingmuller D, Klumper J, Strassburg CP, Rockstroh JK "Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature." Infection (2013):. [PMID: 23873267]
386	Grierson MJ, Harrast MA "Iatrogenic Cushing Syndrome After Epidural Steroid Injections for Lumbar Radiculopathy in an HIV-Infected Patient Treated With Ritonavir: A Case Report Highlighting Drug Interactions for Spine Interventionalists." PM R 4 (2012): 234-7. [PMID: 22443962]
387	Antoniou T, Tseng AL "Interactions between antiretrovirals and antineoplastic drug therapy." Clin Pharmacokinet 44 (2005): 111-145. [PMID: 15656694]
388	Ariffin H, Omar KZ, Ang EL, Shekhar K "Severe vincristine neurotoxicity with concomitant use of itraconazole." J Paediatr Child Health 39 (2003): 638-9. [PMID: 14629538]
389	Bashir H, Motl S, Metzger ML, et al. "Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma." J Pediatr Hematol Oncol 28 (2006): 33-35. [PMID: 16394890]
390	Bermudez M, Fuster JL, Llinares E, Galera A, Gonzalez C "Itraconazole-related increased vincristine neurotoxicity: case report and review of literature." J Pediatr Hematol Oncol 27 (2005): 389-392. [PMID: 16012330]
391	Bohme A, Ganser A, Hoelzer D "Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL." Ann Hematol 71 (1995): 311-2. [PMID: 8534764]
392	Bosque E "Possible drug interaction between itraconazole and vinorelbine tartrate leading to death after one dose of chemotherapy." Ann Intern Med 134 (2001): 427. [PMID: 11242511]
393	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
394	Chan JD "Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports." Pharmacotherapy 18 (1998): 1304-7. [PMID: 9855331]
395	Chen S, Wu D, Sun A, et al "Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia." Am J Hematol 82 (2007): 942. [PMID: 17617780]
396	Corona G, Vaccher E, Spina M, Toffoli G "Potential hazard drug-drug interaction between boosted protease inhibitors and vinblastine in HIV patients with Hodgkin's lymphoma." AIDS 27 (2013): 1033-5. [PMID: 23698067]
397	Eiden C, Palenzuela G, Hillaire-Buys D, et al. "Posaconazole-increased vincristine neurotoxicity in a child: a case report." J Pediatr Hematol Oncol 31 (2009): 292-5. [PMID: 19346885]
398	Fedeli L, Colozza M, Boschetti E, et al. "Pharmacokinetics of vincristine in cancer patients treated with nifedipine." Cancer 64 (1989): 1805-11. [PMID: 2790693]
399	Gillies J, Hung KA, Fitzsimons E, Soutar R "Severe vincristine toxicity in combination with itraconazole." Clin Lab Haematol 20 (1998): 123-4. [PMID: 9681224]
400	Haddad A, Davis M, Lagman R "The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions." Support Care Cancer 15 (2007): 251-7. [PMID: 17139496]
401	Harnicar S, Adel N, Jurcic J "Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients." J Oncol Pharm Pract 15 (2009): 175-82. [PMID: 19282418]
402	Jain S, Kapoor G "Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine." Pediatr Blood Cancer 54 (2010): 783. [PMID: 20205256]
403	Jeng MR, Feusner J "Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia." Pediatr Hematol Oncol 18 (2001): 137-42. [PMID: 11255732]
404	Kajita J, Kuwabara T, Kobayashi H, Kobayashi S "CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes." Drug Metab Dispos 28 (2000): 1121-7. [PMID: 10950859]
405	Kamaluddin M, McNally P, Breatnach F, et al "Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies." Acta Paediatr 90 (2001): 1204-7. [PMID: 11697438]
406	Kivisto KT, Kroemer HK, Eichelbaum M "The role of human cytochrome p450 enzymes in the metabolism of anticancer agents: implications for drug interactions." Br J Clin Pharmacol 40 (1995): 523-30. [PMID: 8703657]
407	Kotb R, Vincent I, Dulioust A, et al. "Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease." Eur J Haematol 76 (2006): 269-71. [PMID: 16451402]
408	Leveque D, Santucci R, Pavillet J, Herbrecht R, Bergerat JP "Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine." Pharm World Sci 31 (2009): 619-21. [PMID: 19757141]
409	Mantadakis E, Amoiridis G, Kondi A, Kalmanti M "Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia." J Pediatr Hematol Oncol 29 (2007): 130. [PMID: 17279013]
410	Moriyama B, Falade-Nwulia O, Leung J, et al. "Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction." Mycoses 54 (2011): e877-9. [PMID: 21615537]
411	Murphy JA, Ross LM, Gibson BE "Vincristine toxicity in five children with acute lymphoblastic leukaemia." Lancet 346 (1995): 443. [PMID: 7623589]
412	Porter CC, Carver AE, Albano EA "Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X." Pediatr Blood Cancer 52 (2009): 298-300. [PMID: 18837430]
413	Product Information. Oncovin (vincristine). Lilly, Eli and Company, Indianapolis, IN.
414	Product Information. Velban (vinblastine). Lilly, Eli and Company, Indianapolis, IN.
415	Sathiapalan RK, Al-Nasser A, El-Solh H, Al-Mohsen I, Al-Jumaah S "Vincristine-itraconazole interaction: cause for increasing concern." J Pediatr Hematol Oncol 24 (2002): 591. [PMID: 12368705]
416	Sathiapalan RK, El-Solh H "Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature." Pediatr Hematol Oncol 18 (2001): 543-6. [PMID: 11764105]
417	Takahashi N, Kameoka Y, Yamanaka Y, et al. "Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma." Intern Med 47 (2008): 651-3. [PMID: 18379154]
418	Tobe SW, Siu LL, Jamal SA, Skorecki KL, Murphy GF, Warner E "Vinblastine and erythromycin: an unrecognized serious drug interaction." Cancer Chemother Pharmacol 35 (1995): 188-90. [PMID: 7805175]
419	Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y "Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors." Cancer Res 43 (1983): 2267-72. [PMID: 6831450]
420	van Schie RM, Bruggemann RJ, Hoogerbrugge PM, Te Loo DM "Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia." J Antimicrob Chemother 66 (2011): 1853-6. [PMID: 21652620]
421	Yano R, Tani D, Watanabe K, et al. "Evaluation of potential interaction between vinorelbine and clarithromycin." Ann Pharmacother 43 (2009): 453-8. [PMID: 19261952]
422	Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
423	Zhou-Pan XR, Seree E, Zhou XJ, et al "Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions." Cancer Res 53 (1993): 5121-6. [PMID: 8221648]
424	Jori A, Carrara MC "On the mechanism of the hyperglycaemic effect of chlorpromazine." J Pharm Pharmacol 18 (1966): 623-4. [PMID: 4381950]
425	Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
426	Product Information. Thorazine (chlorpromazine). SmithKline Beecham, Philadelphia, PA.
427	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
428	Product Information. Axert (almotriptan) Pharmacia and Upjohn, Kalamazoo, MI.
429	Product Information. Lotronex (alosetron). Glaxo Wellcome, Research Triangle Park, NC.
430	Product Information. Xanax (alprazolam). Pharmacia and Upjohn, Kalamazoo, MI.
431	Brooks J, Daily J, Schwamm L "Protease inhibitors and anticonvulsants." AIDS Clin Care 9 (1997): 87,90. [PMID: 11364776]
432	Hugen PWH, Burger DM, Brinkman K, terHofstede HJM, Schuurman R, Koopmans PP, Hekster YA "Carbamazepine-indinavir interaction causes antiretroviral therapy failure." Ann Pharmacother 34 (2000): 465-70. [PMID: 10772431]
433	Liedtke MD, Lockhart SM, Rathbun RC "Anticonvulsant and antiretroviral interactions." Ann Pharmacother 38 (2004): 482-9. [PMID: 14970370]
434	Eap CB, Bender S, Gastpar M, et al "Steady state plasma levels of the enantiomers of trimipramine and its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients." Ther Drug Monit 22 (2000): 209-14. [PMID: 10774635]
435	Ghahramani P, Ellis SW, Lennard MS, Ramsay LE, Tucker GT "Cytochromes p450 mediating the n-demethylation of amitriptyline." Br J Clin Pharmacol 43 (1997): 137-44. [PMID: 9131945]
436	Haritos VS, Ghabrial H, Ahokas JT, Ching MS "Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin." Pharmacogenetics 10 (2000): 591-603. [PMID: 11037801]
437	Hartter S, Tybring G, Friedberg T, Weigmann H, Hiemke C "The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19." Pharm Res 19 (2002): 1034-7. [PMID: 12180536]
438	Kirchheiner J, Meineke I, Muller G, Roots I, Brockmoller J "Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers." Pharmacogenetics 12 (2002): 571-80. [PMID: 12360109]
439	Kirchheiner J, Muller G, Meineke I, Wernecke KD, Roots I, Brockmoller J "Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics." J Clin Psychopharmacol 23 (2003): 459-66. [PMID: 14520122]
440	Nielsen KK, Flinois JP, Beaune P, Brosen K "The biotransformation of clomipramine in vitro, identification of the cytochrome p450s responsible for the separate metabolic pathways." J Pharmacol Exp Ther 277 (1996): 1659-64. [PMID: 8667235]
441	Shimoda K, Someya T, Yokono A, et al. "The Impact of CYP2C19 and CYP2D6 Genotypes on Metabolism of Amitriptyline in Japanese Psychiatric Patients." J Clin Psychopharmacol 22 (2002): 371-378. [PMID: 12172336]
442	Tacke U, Leinonen E, Lillsunde P, et al "Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations." J Clin Psychopharmacol 12 (1992): 262-7. [PMID: 1527229]
443	Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI "Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4." J Clin Pharmacol 38 (1998): 112-21. [PMID: 9549641]
444	Venkatakrishnan K, Schmider J, Harmatz JS, et al. "Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies." J Clin Pharmacol 41 (2001): 1043-54. [PMID: 11583471]
445	Yang TJ, Krausz KW, Sai Y, Gonzalez FJ, Gelbon HV "Eight inhibitory monoclonal antibodies define the role of individual P-450S in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism." Drug Metab Dispos 27 (1999): 102-9. [PMID: 9884317]
446	von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Duan SX, Harmatz JS, Shader RI "Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo." J Pharmacol Exp Ther 268 (1994): 1278-83. [PMID: 8138941]
447	Vonmoltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI "Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants." J Clin Psychopharmacol 15 (1995): 125-31. [PMID: 7782485]
448	Product Information. Norvasc (amlodipine). Pfizer US Pharmaceuticals, New York, NY.
449	Sasaki M, Maeda A, Fujimura A "Influence of diltiazem on the pharmacokinetics of amlodipine in elderly hypertensive patients." Eur J Clin Pharmacol 57 (2001): 85-6. [PMID: 11372598]
450	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
451	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
452	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
453	Busse KH, Formentini E, Alfaro RM, Kovacs JA, Penzak SR "Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals." J Acquir Immune Defic Syndr 48 (2008): 561-6. [PMID: 18645517]
454	Couturier J, Steele M, Hussey L, Pawliuk G "Steroid-induced mania in an adolescent: risk factors and management." Can J Clin Pharmacol 8 (2001): 109-12. [PMID: 11493940]
455	Finkenbine RD, Frye MD "Case of psychosis due to prednisone-clarithromycin interaction." Gen Hosp Psychiat 20 (1998): 325-6. [PMID: 9788033]
456	Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH "Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma." Chest 118 (2000): 1826-7. [PMID: 11115481]
457	Itkin IH, Menzel ML "The use of macrolide antibiotic substances in the treatment of asthma." J Allergy Clin Immunol 45 (1970): 146-62. [PMID: 5309312]
458	Lebrun-Vignes B, Archer VC, Diquest B, et al. "Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects." Br J Clin Pharmacol 51 (2001): 443-50. [PMID: 11422002]
459	Penzak SR, Formentini E, Alfaro RM, Long M, Natarajan V, Kovacs J "Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers." J Acquir Immune Defic Syndr 40 (2005): 573-80. [PMID: 16284534]
460	Ulrich B, Frey FJ, Speck RF, Frey BM "Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction." J Pharmacol Exp Ther 260 (1992): 487-90. [PMID: 1738098]
461	Varis T, Kivisto KT, Neuvonen PJ "The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone." Eur J Clin Pharmacol 56 (2000): 57-60. [PMID: 10853878]
462	Yamashita SK, Ludwig EA, Middleton E Jr, Jusko WJ "Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone." Clin Pharmacol Ther 49 (1991): 558-70. [PMID: 1827622]
463	Zurcher RM, Frey BM, Frey FJ "Impact of ketoconazole on the metabolism of prednisolone." Clin Pharmacol Ther 45 (1989): 366-72. [PMID: 2639662]
464	Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
465	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
466	Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
467	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
468	Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
469	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
470	Product Information. Sensipar (cinacalcet). Amgen USA, Thousand Oaks, CA.
471	Product Information. Cleocin (clindamycin). Pharmacia and Upjohn, Kalamazoo, MI.
472	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
473	Product Information. Cardura (doxazosin). Pfizer US Pharmaceuticals, New York, NY.
474	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
475	Lemma GL, Desta Z, Jones DR, Gorski JC, Hall SD "Droperidol is predominantly metabolized by human CYP3A enzymes." Clin Pharmacol Ther 73 (2003): 16.
476	Product Information. Droperidol (droperidol). Abbott Pharmaceutical, Abbott Park, IL.
477	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
478	Product Information. Duagen (dutasteride). GlaxoSmithKline Healthcare, Pittsburgh, PA.
479	Duval X, Le Moing V, Longuet P, et al "Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir." Antimicrob Agents Chemother 44 (2000): 2593. [PMID: 11012391]
480	Wintergerst U, Engelhorn C, Kurowski M, Hoffmann F, Notheis G, Belohradsky BH "Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children." Aids 14 (2000): 1866-8. [PMID: 10985332]
481	Falloon J, Piscitelli S, Vogel S, Sadler B, Mitsuya H, Kavlick MF, Yoshimura K, Rogers M, LaFon S, Manion DJ, Lane HC, Masur "Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity." Clin Infect Dis 30 (2000): 313-8. [PMID: 10671334]
482	Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
483	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
484	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
485	Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
486	Product Information. Gilotrif (afatinib). Boehringer Ingelheim, Ridgefield, CT.
487	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
488	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
489	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
490	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
491	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
492	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
493	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
494	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
495	Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
496	Product Information. Alvesco (ciclesonide). Nycomed USA, Florham Park, NJ.
497	Product Information. Omnaris (ciclesonide nasal). Sepracor Inc, Marlborough, MA.
498	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
499	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
500	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
501	Product Information. Stribild (cobicistat/elvitegravir/emtricitabine/tenofov). Gilead Sciences, Foster City, CA.
502	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
503	Product Information. Tybost (cobicistat). Gilead Sciences, Foster City, CA.
504	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
505	Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
506	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
507	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
508	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
509	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
510	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
511	Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
512	Product Information. Cerebyx (fosphenytoin). Parke-Davis, Morris Plains, NJ.
513	Product Information. Dilantin (phenytoin). Parke-Davis, Morris Plains, NJ.
514	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
515	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
516	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
517	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
518	Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
519	Product Information. Vimpat (lacosamide). UCB Pharma Inc, Smyrna, GA.
520	Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
521	Dutreix C, Munarini F, Lorenzo S, Roesel J, Wang Y "Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers." Cancer Chemother Pharmacol 72 (2013): 1223-34. [PMID: 24085261]
522	Product Information. Rydapt (midostaurin). Novartis Pharmaceuticals, East Hanover, NJ.
523	Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
524	Product Information. Osphena (ospemifene). Shionogi USA Inc, Florham Park, NJ.
525	Hamberg P, Woo MM, Chen LC, et al. "Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor." Cancer Chemother Pharmacol 68 (2011): 805-13. [PMID: 21706316]
526	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
527	Product Information. Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir). AbbVie US LLC, North Chicago, IL.
528	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
529	Product Information. Pomalyst (pomalidomide). QLT Phototherapeutics Inc, Vancouver, AZ.
530	Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
531	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
532	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
533	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
534	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
535	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
536	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
537	Product Information. Istodax (romidepsin). Gloucester Pharmaceuticals, Cambridge, MA.
538	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
539	Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
540	Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
541	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
542	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
543	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
544	Product Information. Kadcyla (ado-trastuzumab). Genentech, South San Francisco, CA.
545	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
546	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
547	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
548	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
549	Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
550	Product Information. Multihance (gadobenate dimeglumine). Bracco Diagnostics Inc, Princeton, NJ.
551	Huisman MT, Smit JW, Crommentuyn KM, et al. "Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs." AIDS 16 (2002): 2295-2301. [PMID: 12441801]
552	Product Information. Reminyl (galantamine) Janssen Pharmaceuticals, Titusville, NJ.
553	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
554	Polk RE, Crouch MA, Israel DS, et al. "Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men." Pharmacotherapy 19 (1999): 1378-84. [PMID: 10600086]
555	Zeng Z, Andrew NW, Arison BH, Luffer-Atlas D, Wang RW "Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes." Xenobiotica 28 (1998): 313-21. [PMID: 9574819]
556	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
557	Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H "Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients." Biochem Pharmacol 93 (2015): 104-9. [PMID: 25475885]
558	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
559	Sitsen JM, Maris FA, Timmer CJ "Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 56 (2000): 389-94. [PMID: 11009047]
560	Stormer E, von Moltke LL, Shader RI, Greenblatt DJ "Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4" Drug Metab Dispos 28 (2000): 1168-75. [PMID: 10997935]
561	Back D, Gibbons S, Khoo S "Pharmacokinetic drug interactions with nevirapine." J Acquir Immune Defic Syndr 34 Suppl 1 (2003): S8-14. [PMID: 14562853]
562	Merry C, Barry MG, Mulcahy F, Ryan M, Tjia JF, Halifax KL, Breckenridge AM, Back DJ "The pharmacokinetics of combination therapy with nelfinavir plus nevirapine." AIDS 12 (1998): 1163-7. [PMID: 9677165]
563	Mulcahy F, Barry M, Merry C, Back D "Nelfinavir and nevirapine interaction?" AIDS 12 (1998): 2361. [PMID: 9863887]
564	Murphey RL, Sommadossi JP, Lamson M, Hall DB, Myers M, Dusek A "Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1." J Infect Dis 179 (1999): 1116-23. [PMID: 10191212]
565	Skowron G, Leoung C, Kerr B, Dusek A, Anderson R, Beebe S, Grosso R "Lack of pharmacokinetic interaction between nelfinavir and nevirapine." AIDS 12 (1998): 1243-4. [PMID: 9677174]
566	MHRA. Medicines and Healthcare Products Regulatory Agency "Orlistat: theoretical interaction with antiretroviral HIV medicines.".
567	Product Information. Zemplar (paricalcitol). Abbott Pharmaceutical, Abbott Park, IL.
568	Product Information. Rythmol SR (propafenone). GlaxoSmithKline, Research Triangle Park, NC.
569	Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK "Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites." Mol Pharmacol 43 (1993): 120-6. [PMID: 8423765]
570	Mirghani RA, Ericsson O, Tybring G, Gustafsson LL, Bertilsson L "Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man." Eur J Clin Pharmacol 59 (2003): 23-8. [PMID: 12743670]
571	Mirghani RA, Hellgren U, Bertilsson L, Gustafsson LL, Ericsson O "Metabolism and elimination of quinine in healthy volunteers." Eur J Clin Pharmacol (2003):. [PMID: 12920491]
572	Mirghani RA, Hellgren U, Westerberg PA, Ericsson O, Bertilsson L, Gustafsson LL "The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo." Clin Pharmacol Ther 66 (1999): 454-60. [PMID: 10579472]
573	Mirghani RA, Yasar U, Zheng T, et al "Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway." Drug Metab Dispos 30 (2002): 1368-71. [PMID: 12433805]
574	Product Information. Qualaquin (quinine). AR Scientific Inc, Philadelphia, PA.
575	Wanwimolruk S, Paine MF, Pusek SN, Watkins PB "Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?" Br J Clin Pharmacol 54 (2002): 643-51. [PMID: 12492613]
576	Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S "Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine." Br J Clin Pharmacol 43 (1997): 245-52. [PMID: 9088578]
577	Zhao XJ, Ishizaki T "A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (K-i) and type of inhibition." Eur J Drug Metab Pharm 24 (1999): 272-8. [PMID: 10716067]
578	Zhao XJ, Ishizaki T "Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes." Br J Clin Pharmacol 44 (1997): 505-11. [PMID: 9384469]
579	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
580	Dube MP, Johnson DL, Currier JS, Leedom JM "Protease inhibitor-associated hyperglycaemia." Lancet 350 (1997): 713-4. [PMID: 9291911]
581	Fichtenbaum CJ, Gerber JG "Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection." Clin Pharmacokinet 41 (2002): 1195-211. [PMID: 12405866]
582	Hardy H, Esch LD, Morse GD "Glucose disorders associated with HIV and its drug therapy." Ann Pharmacother 35 (2001): 343-51. [PMID: 11261533]
583	Kaufman MB, Simionatto C "A review of protease inhibitor-induced hyperglycemia." Pharmacotherapy 19 (1999): 114-7. [PMID: 9917085]
584	Mauss S, Wolf E, Jaeger H "Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors." Ann Intern Med 130 (1999): 162-3. [PMID: 10068370]
585	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
586	Tsiodras S, Mantzoros C, Hammer S, Samore M "Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy - A 5-year cohort study." Arch Intern Med 160 (2000): 2050-6. [PMID: 10888979]
587	Walli R, Demant T "Impaired glucose tolerance and protease inhibitors." Ann Intern Med 129 (1998): 837-8. [PMID: 9841594]
588	American Thoracic Society, CDC, Infectious Diseases Society of America "Treatment of tuberculosis." MMWR Morb Mortal Wkly Rep 52(RR-11) (2003): 1-77. [PMID: 12836625]
589	Burman WJ, Jones BE "Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy." Am J Respir Crit Care Med 164 (2001): 7-12. [PMID: 11435232]
590	Fournier S, Deplus S, Janier M, Poinsignon Y, Decazes JM, Modai J "Anterior uveitis in 3 HIV-infected patients treated with antiprotease." Presse Med 27 (1998): 844-8. [PMID: 9767867]
591	Gariano RF, Gooney EL "Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS." Clin Infect Dis 24 (1997): 529. [PMID: 9114223]
592	Polk RE, Brophy DF, Israel DS, Patron R, Sadler BM, Chittick GE, Symonds WT, Lou Y, Kristoff D, Stein DS "Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males." Antimicrob Agents Chemother 45 (2001): 502-8. [PMID: 11158747]
593	Notice to readers: updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibiotrs. MMWR Morb Mortal Wkly Rep 49 (2000): 185-9. [PMID: 11795500]
594	Bartkowski RR, Goldberg ME, Huffnagle S, Epstein RH "Sufentanil disposition. Is it affected by erythromycin administration?" Anesthesiology 78 (1993): 260-5. [PMID: 8439020]
595	Product Information. Sufenta (sufentanil). Janssen Pharmaceutica, Titusville, NJ.
596	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
597	Loulergue P, Gaillard R, Mir O "Interaction involving tadalafil and CYP3A4 inhibition by ritonavir." Scand J Infect Dis 43 (2011): 239-40. [PMID: 20942777]
598	Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
599	Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
600	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
601	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
602	Brynne N, Forslund C, Hallen B, Gustafsson LL, Bertilsson L "Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity." Br J Clin Pharmacol 48 (1999): 564-72. [PMID: 10583027]
603	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.
604	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
605	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
606	Greenblatt DJ, von Moltke LL, Harmatz JS, et al. "Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone." J Clin Pharmacol 43 (2003): 414-22. [PMID: 12723462]
607	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
608	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
609	Product Information. Desyrel (trazodone). Bristol-Myers Squibb, Princeton, NJ.
610	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
611	Adamson PC "Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia." Semin Hematol 31 (1994): 14-7. [PMID: 7831580]
612	Cordoba R, Ramirez E, Lei SH, et al. "Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid." Eur J Clin Pharmacol 64 (2008): 1031-2. [PMID: 18584165]
613	Dixon KS, Hassoun A "Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole." J Am Pharm Assoc (2003) 50 (2010): 742-4. [PMID: 21071321]
614	Hameed DA, el-Metwally TH "The effectiveness of retinoic acid treatment in bladder cancer: impact on recurrence, survival and TGFalpha and VEGF as end-point biomarkers." Cancer Biol Ther 7 (2008): 92-100. [PMID: 18347417]
615	Kizaki M, Ueno H, Yamazoe Y, et al "Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein." Blood 87 (1996): 725-33. [PMID: 8555497]
616	Lotan Y, Lotan R "Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?" Cancer Biol Ther 7 (2008): 101-2. [PMID: 18347420]
617	Marill J, Cresteil T, Lanotte M, Chabot GG "Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites." Mol Pharmacol 58 (2000): 1341-8. [PMID: 11093772]
618	Moresco G, Martinello F, Souza LC "[Acute renal failure in patient treated with ATRA and amphotericin B: case report]." J Bras Nefrol 33 (2011): 276-81. [PMID: 21789447]
619	Muindi JRF, Young CW, Warrell RP "Clinical pharmacology of all-trans retinoic acid." Leukemia 8 (1994): 1807-12. [PMID: 7967726]
620	Product Information. Vesanoid (tretinoin). Roche Laboratories, Nutley, NJ.
621	Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr "Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole." J Natl Cancer Inst 85 (1993): 1921-6. [PMID: 8230282]
622	Product Information. Levitra (vardenafil). Bayer, West Haven, CT.
623	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
624	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
625	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
626	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
627	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
628	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
629	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
630	Product Information. Letairis (ambrisentan). Gilead Sciences, Foster City, CA.
631	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
632	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
633	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
634	Product Information. Xerava (eravacycline). Tetraphase Pharmaceuticals, Inc, Watertown, MA.
635	Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
636	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
637	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
638	Product Information. ella (ulipristal). Afaxys Inc., Charleston, SC.
639	Product Information. Elidel (pimecrolimus topical). Novartis Pharmaceuticals, East Hanover, NJ.
640	Product Information. Altabax (retapamulin topical). GlaxoSmithKline, Research Triangle Park, NC.
641	Ekstrom G, Gunnarsson UB "Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes." Drug Metab Dispos 24 (1996): 955-61. [PMID: 8886604]
642	Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M "Metabolism and excretion of ropivacaine in humans." Drug Metab Dispos 24 (1996): 962-8. [PMID: 8886605]
643	Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT "The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine." Anesth Analg 91 (2000): 1207-12. [PMID: 11049910]
644	McClure JH "Ropivacaine." Br J Anaesth 76 (1996): 300-7. [PMID: 8777115]
645	Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y "Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450." Anesthesiology 82 (1995): 214-20. [PMID: 7832304]
646	Product Information. Naropin (ropivacaine). Astra USA, Westborough, MA.
647	Arlander E, Ekstrom G, Alm C, Carrillo JA, Bielenstein M, Bottiger Y, Bertilsson L, Gustafsson LL "Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors." Clin Pharmacol Ther 64 (1998): 484-91. [PMID: 9834040]
648	Miceli JJ, Smith M, Robarge L, Morse T, Laurent A "The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers." Br J Clin Pharmacol 49(suppl 1) (2000): s71-6. [PMID: 10771458]
649	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
650	Wilner KD, Hansen RA, Folger CJ, Geoffroy P "The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid." Br J Clin Pharmacol 49(Suppl 1) (2000): 57S-60S. [PMID: 10771455]
651	Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D "Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions." Br J Clin Pharmacol 49(Suppl 1) (2000): 35S-42S. [PMID: 10771452]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence